Cite Filings / KROS / 0001664710-22-000011
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
10-K

Annual Report

Keros Therapeutics, Inc. · Filed 2022-03-09 · Acc 0001664710-22-000011

Documents 1

  • 10-K Annual Report , kros-20211231.htm

Around this filing

  • 2023-03-03 10-K Annual Report
  • 2022-03-15 4 Chief Scientific Officer sold 2,650 shares at an average $53.38 ($141,449)
  • 2022-03-09 S-8 Securities Offered to Employees in Benefit Plans
  • 2022-03-09 8-K Regulation FD disclosure
  • 2022-03-09 10-K Annual Report
  • 2022-03-09 8-K Results of operations
  • 2021-03-25 10-K Annual Report

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
  • SEC Structured Data (opens in new tab)
Loading kros-20211231.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…